Clinical Image : Pamidronate zebra linesVINSON, Emily N.Arthritis and rheumatism. 2008, Vol 58, Num 9, pp 2817-2817, issn 0004-3591, 1 p.Article

Pincer nails associated with pamidronateFAILLA, V; RICHERT, B. J. S; NIKKELS, A. F et al.Clinical and experimental dermatology (Print). 2011, Vol 36, Num 3, pp 305-306, issn 0307-6938, 2 p.Article

Dysplasie fibreuse polyostotique: à propos d'un casRIDENE, M.La Lettre du rhumatologue. 2010, Num 360, pp 8-9, issn 0761-5027, 2 p., SUP1Article

Diez casos de osteonecrosis mandíbular (ONM) asociada a bisfosfonatos = Ten cases of osteonecrosis of the jaw related with biphosphonatesFERREIRO, S. Varela; OZORES, P. Palacios; SALGADO BOQUETE, L et al.Oncología (Barcelona). 2007, Vol 30, Num 4, pp 13-21, issn 0378-4835, 9 p.Article

Progressive osseous heteroplasia controlled by intravenous administration of pamidronateHOU, Jia-Woei.American journal of medical genetics. Part A. 2006, Vol 140, Num 8, pp 910-913, issn 1552-4825, 4 p.Article

Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusionsSTEELMAN, Joel; ZEITLER, Philip.The Journal of pediatrics. 2003, Vol 142, Num 4, pp 417-423, issn 0022-3476, 7 p.Article

Bisphosphonates for the treatment of Charcot neuroarthropathyANDERSON, John J; WOELFFER, Kirk E; HOLTZMAN, John J et al.The Journal of foot and ankle surgery. 2004, Vol 43, Num 5, pp 285-289, issn 1067-2516, 5 p.Article

Inhibition of bone healing by pamidronate in calvarial bony defectsCHOI, Je-Yong; KIM, Hyung-Jong; LEE, Yong-Chan et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2007, Vol 103, Num 3, pp 321-328, issn 1079-2104, 8 p.Article

Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinomaWADA, Akira; FUKUI, Koji; SAWAI, Yoshiyuki et al.Journal of hepatology. 2006, Vol 44, Num 1, pp 142-150, issn 0168-8278, 9 p.Article

The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndromeSOLAU-GERVAIS, E; SOUBRIER, M; GEROT, I et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 3, pp 339-342, issn 1462-0324, 4 p.Article

Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapyTAU, Cristina; MAUTALEN, Carlos; CASCO, Cristina et al.Bone (New York, NY). 2004, Vol 35, Num 1, pp 210-216, issn 8756-3282, 7 p.Article

SAPHO syndrome treated with pamidronate: an open-label study of 10 patientsAMITAL, H; APPLBAUM, Y. H; AAMAR, S et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 5, pp 658-661, issn 1462-0324, 4 p.Article

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesionROSEN, Lee S; GORDON, David H; COLEMAN, Robert E et al.Cancer. 2004, Vol 100, Num 1, pp 36-43, issn 0008-543X, 8 p.Article

Treatment of langerhans cell histiocytosis with pamidronateFARRAN, R. Peter; ZARETSKI, Eldon; EGELER, R. Maarten et al.Journal of pediatric hematology/oncology. 2001, Vol 23, Num 1, pp 54-56, issn 1077-4114Article

Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trialJUDE, E. B; SELBY, P. L; BURGESS, J et al.Diabetologia (Berlin). 2001, Vol 44, Num 11, pp 2032-2037, issn 0012-186XArticle

Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonatesGUYOT-DROUOT, Marie-Helene; SOLAU-GERVAIS, Elisabeth; CORTET, Bernard et al.Journal of rheumatology. 2000, Vol 27, Num 10, pp 2418-2423, issn 0315-162XArticle

Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodiumSTEWART, G. O; GUTTERIDGE, D. H; PRICE, R. I et al.Bone (New York, NY). 1999, Vol 24, Num 2, pp 139-144, issn 8756-3282Article

Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronateYAMAZAKI, Yutaka; SATOH, Chiharu; ISHIKAWA, Makoto et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2007, Vol 104, Num 1, pp 67-71, issn 1079-2104, 5 p.Article

Pamidronate reduces bone loss after allogeneic stem cell transplantationGRIGG, A. P; SHUTTLEWORTH, P; REYNOLDS, J et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 10, pp 3835-3843, issn 0021-972X, 9 p.Article

Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosisCAUZA, E; ETEMAD, M; WINKLER, F et al.Journal of clinical pharmacy and therapeutics (Print). 2004, Vol 29, Num 5, pp 431-436, issn 0269-4727, 6 p.Article

Radiographic lonq bone appearance in a child administered cyclical pamidronateDAVIES, J. H; GREGORY, J. W.Archives of disease in childhood. 2003, Vol 88, Num 10, issn 0003-9888, p. 854Article

Dysplasie fibreuse = Fibrous dysplasiaBOLLINI, G.Cahiers d'enseignement de la SOFCOT. 2003, Vol 82, pp 185-201, issn 0338-3849, 17 p.Article

Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronateMONTAGNANI, A; GONNELLI, S; CEPOLLARO, C et al.Bone (New York, NY). 2003, Vol 32, Num 1, pp 15-19, issn 8756-3282, 5 p.Article

Semi-automatic liquid chromatographic analysis of pamidronate in serum and citrate plasma after derivatization with 1-naphthylisothiocyanateSPARIDANS, R. W; DEN HARTIGH, J; BEIJNEN, J. H et al.Journal of chromatography. B, Biomedical sciences and applications. 1998, Vol 705, Num 2, pp 331-339, issn 1387-2273Article

Childhood cancer and hypercalcemia : Report of a case treated with pamidronateTEZER KUTLUK, M; HAZAR, V; AKYÜZ, C et al.The Journal of pediatrics. 1997, Vol 130, Num 5, pp 828-831, issn 0022-3476Article